Research Grade Cendakimab (DHE07701)

Catalog No.

DHE07701

Expression system

Mammalian Cells

Species reactivity

Human

Host species

Humanized

Isotype

IgG1-kappa

Clonality

Monoclonal

Target

IL13, NC30, Interleukin-13, IL-13

Concentration

5.25 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P35225

Applications

Research Grade Biosimilar

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Alternative Names

13C5.5, ABT-308, RPC-4046, CAS: 2151032-62-9

Clone ID

Cendakimab

Long-term Efficacy and Tolerability of RPC4046 in an Open-Label Extension Trial of Patients With Eosinophilic Esophagitis, PMID: 32205221

One If By Steroids and Two If By Biologic, PMID: 30641052

RPC4046, a Monoclonal Antibody Against IL13, Reduces Histologic and Endoscopic Activity in Patients With Eosinophilic Esophagitis, PMID: 30395812

RPC4046, A Novel Anti-interleukin-13 Antibody, Blocks IL-13 Binding to IL-13 α1 and α2 Receptors: A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation First-in-Human Study, PMID: 28455782

Targeted Therapies for Eosinophilic Gastrointestinal Disorders, PMID: 32472465

Document Download

Research Grade Cendakimab.pdf